Adverum Biotechnologies Inc logo

Adverum Biotechnologies Inc

NAS:ADVM (USA)  
$ 2.02 -0.1 (-4.76%) 10:08 PM EST
At Loss
P/B:
1.99
Market Cap:
$ 204.07M
Enterprise V:
$ 162.52M
Volume:
1.08M
Avg Vol (2M):
2.42M
Also Trade In:
Volume:
1.08M
At Loss
Avg Vol (2M):
2.42M

Business Description

Adverum Biotechnologies Inc logo
Adverum Biotechnologies Inc
NAICS : 325412 SIC : 2834
ISIN : US00773U1088
Description
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.
Name Current Vs Industry Vs History
Cash-To-Debt 1.55
Equity-to-Asset 0.52
Debt-to-Equity 0.74
Debt-to-EBITDA -0.6
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.59
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 51.54
9-Day RSI 56.2
14-Day RSI 58.5
6-1 Month Momentum % -48.26
12-1 Month Momentum % 23.43

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.32
Quick Ratio 4.32
Cash Ratio 4.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.1
Shareholder Yield % 5.59

Financials (Next Earnings Date:2024-03-29 Est.)

ADVM's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ADVM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Adverum Biotechnologies Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3.6
EPS (TTM) ($) -1.26
Beta 0.72
Volatility % 98.51
14-Day RSI 58.5
14-Day ATR ($) 0.289717
20-Day SMA ($) 1.805475
12-1 Month Momentum % 23.43
52-Week Range ($) 0.67 - 2.97
Shares Outstanding (Mil) 101.03

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Adverum Biotechnologies Inc Filings

Filing Date Document Date Form
No Filing Data

Adverum Biotechnologies Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Adverum Biotechnologies Inc Frequently Asked Questions

What is Adverum Biotechnologies Inc(ADVM)'s stock price today?
The current price of ADVM is $2.02. The 52 week high of ADVM is $2.97 and 52 week low is $0.67.
When is next earnings date of Adverum Biotechnologies Inc(ADVM)?
The next earnings date of Adverum Biotechnologies Inc(ADVM) is 2024-03-29 Est..
Does Adverum Biotechnologies Inc(ADVM) pay dividends? If so, how much?
Adverum Biotechnologies Inc(ADVM) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1